TriSalus Life Sciences, Inc. — Director's Dealing 2026

Feb 23, 2026

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TriSalus Life Sciences, Inc. (TLSI)
CIK: 0001826667
Period of Report: 2026-02-23

Reporting Person: Stansky Michael P (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2026-02-23	Common Stock	P	243900	$4.10	Acquired	787132	Direct
2026-02-23	Common Stock	P	117198	$4.10	Acquired	199698	Indirect

Footnotes

F1: These securities were purchased by Skyview Investments LLC. Mr. Stansky serves as managing member of Skyview Investments LLC (and in such capacity may be deemed to beneficially own the securities reported herein). Voting and dispositive power over the securities owned by Skyview Investments LLC is exercised in his capacity as managing member.